CareDx, Inc. (CDNA)
49.48
+1.98
(+4.17%)
USD |
NASDAQ |
Aug 25, 11:51
CareDx Enterprise Value : 2.091B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.091B |
| August 21, 2026 | 2.148B |
| August 20, 2026 | 2.065B |
| August 19, 2026 | 2.040B |
| August 18, 2026 | 2.023B |
| August 17, 2026 | 2.033B |
| August 14, 2026 | 1.979B |
| August 13, 2026 | 2.085B |
| August 12, 2026 | 2.081B |
| August 11, 2026 | 2.077B |
| August 10, 2026 | 2.069B |
| August 07, 2026 | 2.049B |
| August 06, 2026 | 1.953B |
| August 05, 2026 | 1.988B |
| August 04, 2026 | 2.070B |
| August 03, 2026 | 2.109B |
| July 31, 2026 | 1.896B |
| July 30, 2026 | 1.607B |
| July 29, 2026 | 1.469B |
| July 28, 2026 | 1.486B |
| July 27, 2026 | 1.518B |
| July 24, 2026 | 1.558B |
| July 23, 2026 | 1.582B |
| July 22, 2026 | 1.591B |
| July 21, 2026 | 1.630B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.621B |
| July 17, 2026 | 1.691B |
| July 16, 2026 | 1.722B |
| July 15, 2026 | 1.177B |
| July 14, 2026 | 1.135B |
| July 13, 2026 | 1.126B |
| July 10, 2026 | 1.113B |
| July 09, 2026 | 1.144B |
| July 08, 2026 | 1.064B |
| July 07, 2026 | 1.103B |
| July 06, 2026 | 1.142B |
| July 02, 2026 | 1.148B |
| July 01, 2026 | 1.151B |
| June 30, 2026 | 1.113B |
| June 29, 2026 | 1.339B |
| June 26, 2026 | 1.315B |
| June 25, 2026 | 1.265B |
| June 24, 2026 | 1.228B |
| June 23, 2026 | 1.125B |
| June 22, 2026 | 1.122B |
| June 18, 2026 | 1.180B |
| June 17, 2026 | 1.041B |
| June 16, 2026 | 1.029B |
| June 15, 2026 | 1.072B |
| June 12, 2026 | 1.015B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 46.21B |
| Caris Life Sciences, Inc. | 7.043B |
| Myriad Genetics, Inc. | 386.88M |
| BioRestorative Therapies, Inc. | 1.874M |
| Exagen, Inc. | 188.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 110.64M |
| Revenue (Quarterly) | 131.95M |
| Total Expenses (Quarterly) | 21.31M |
| EPS Diluted (Quarterly) | 2.071 |
| Gross Profit Margin (Quarterly) | 73.37% |
| Profit Margin (Quarterly) | 83.85% |
| Earnings Yield | 4.19% |
| Normalized Earnings Yield | 4.273 |